StockWatch
·
Filing
Q1

Artemis Medicare Services Ltd

ARTEMISMEDFY2605 Aug 2025
Revenue+6.3%
Net Profit-7.5%
OPM16.24%

P&L

Quarterly Consolidated

Revenue
+6.3%254.96
Expenditure
+3.8%232.10
Net Profit
-7.5%21.20
NPM 8.09%-11.0%EPS ₹1.35-8.2%

vs Q4 FY25

Artemis Medicare Services Ltd Reports 14.4% Gross Revenue Growth in Q1 FY2025-26

05 Aug 2025 · 5 Aug 2025, 06:15 pm

Summary

Artemis Medicare Services Ltd reported a 14.4% increase in consolidated gross revenue for the quarter ended June 30, 2025. The net revenue from operations was up 14.2% and EBITDA reported was Rs 483 Million at a margin of 19.0%. Net profit for Q1 closed at Rs 212 Million. The company added new beds at its flagship hospital's third tower and signed a binding MoU with Dr. Vidya Sagar Kaushalya Devi Memorial Health Centre.

Key Highlights

  1. 1

    Q1 FY2025-26 consolidated gross revenue up 14.4% (YoY)

  2. 2

    EBITDA up 19.1%

  3. 3

    Net Profit up 28.2%

  4. 4

    Average gross revenue per occupied bed (ARPOB) at Rs 83,900

  5. 5

    Net Revenue from operations up 16.0%

  6. 6

    Bed capacity utilisation at 61.2%

  7. 7

    Revenues from overseas patients increased by 31.4%

  8. 8

    New beds added at the flagship hospital's third tower

  9. 9

    Signed a binding MoU with Dr. Vidya Sagar Kaushalya Devi Memorial Health Centre

Management Comments

O

Onkar Kanwar

Chairman, Artemis Medicare Services Ltd

We are pleased to announce a strong start to FY26, with Q1 delivering consistent growth and resilient operational performance despite being a seasonally soft quarter. Our continued focus on cost optimization, operational efficiency, and disciplined execution has enabled us to maintain healthy profitability and margins. Our highest-ever ARPOB, driven by an optimized case and payer mix and strong international patient inflow, reinforces our position as a leader in Medical Value Travel. Looking ahead, we remain focused on sustainable growth through operational excellence, geographic expansion and strategic partnerships, as we continue building Artemis into one of India’s most trusted healthcare brands.

Informational and educational content only. Not investment advice.